Connect Biopharma Holdings Limited (CNTB)

Price & Market Data

Price: $2.70

Daily Change: +$0.36 / 13.33%

Daily Range: $2.36 - $2.70

Market Cap: $151,477,040

Daily Volume: 233,794

Performance Metrics

1 Week: 8.50%

1 Month: -5.30%

3 Months: 1.13%

6 Months: 72.90%

1 Year: 234.0%

YTD: -4.96%

About Connect Biopharma Holdings Limited (CNTB)

Stay updated on Connect Biopharma Holdings Limited (CNTB). Price: 2.70, daily change: +$0.36 / 13.33%. Market cap: 151,477,040. Performance YTD, 1-week, and 52-week are key.

Company Details

Employees: 64

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.

Selected stocks

Meridian Holdings Inc. (MRDN)

BlackRock Credit Allocation Income Trust (BTZ)

International Tower Hill Mines, Ltd. (THM)

Nuveen Mortgage and Income Fund (JLS)

Enphase Energy, Inc. (ENPH)